Correlation Between Eliem Therapeutics and Oruka Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Oruka Therapeutics,, you can compare the effects of market volatilities on Eliem Therapeutics and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Oruka Therapeutics,.
Diversification Opportunities for Eliem Therapeutics and Oruka Therapeutics,
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eliem and Oruka is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Oruka Therapeutics, go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Oruka Therapeutics,
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Oruka Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.08 times less risky than Oruka Therapeutics,. The stock trades about -0.12 of its potential returns per unit of risk. The Oruka Therapeutics, is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,407 in Oruka Therapeutics, on August 30, 2024 and sell it today you would lose (381.00) from holding Oruka Therapeutics, or give up 15.83% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Eliem Therapeutics vs. Oruka Therapeutics,
Performance |
Timeline |
Eliem Therapeutics |
Oruka Therapeutics, |
Eliem Therapeutics and Oruka Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eliem Therapeutics and Oruka Therapeutics,
The main advantage of trading using opposite Eliem Therapeutics and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Oruka Therapeutics, vs. Ikena Oncology | Oruka Therapeutics, vs. Eliem Therapeutics | Oruka Therapeutics, vs. HCW Biologics | Oruka Therapeutics, vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |